ASSAYED, NOT ASSERTEDSee Sample COA->
← Back to catalog

peptide research material

Cagrilintide

Metabolic & GLP-1
Cagrilintide

Purchase options

Cagrilintide purchase details

From $5.39/vial · In stock

Lowest published volume-tier equivalent. View pack prices and order tiers below.

Specifications3 SKUs

2mg*10vials

CAGRILINTIDE-2MG-10VIALS

≥99%

$100.28Tier 1 / 10 vials

MOQ: 1 10 vials

Order T1$200+$100.28
Order T2$2,000+$75.21
Order T3$5,000+$61.42
Order T4$10,000+$53.90

Worldwide shipping to most destinations. Contact us on WhatsApp for special destinations.

Orders are normally prepared for dispatch the next business day. Contact us on WhatsApp for special handling or timing requirements.

For metabolic & glp-1 buyers, PeptideSource uses Cagrilintide as a document-led sourcing record. The identity layer covers CAS 1415456-99-3, formula C194H312N54O59S2, 4409 Da molecular weight; the commercial layer covers sku coverage includes 10mg*10vials · 2mg*10vials · 5mg*10vials, MOQ, order-tier pricing, and repeat-supply fit. COA, HPLC, MS, SDS, storage, and batch notes remain the main procurement evidence.

Buyer fit

Who buys this, and why

Cagrilintide is listed for qualified B2B buyers reviewing metabolic and incretin-pathway research-material sourcing. Procurement teams should compare incretin, amylin, metabolic-pathway, SKU ladder, and batch-file readiness while keeping the page focused on research-material sourcing rather than personal-use, dosing, treatment, or outcome guidance.

Category: Metabolic & GLP-1. GLP-1, GIP, GCG, amylin, lipolytic, and metabolic-pathway materials for commercial sourcing review.

Specifications

Procurement-ready product data

CAS
1415456-99-3
Molecular formula
C194H312N54O59S2
Molecular weight
4409 Da
Appearance
Lyophilized powder or supplied format listed on batch COA
Purity / identity
≥99%
Common vial sizes
10mg*10vials · 2mg*10vials · 5mg*10vials
Storage
Store according to the batch COA and product handling note.

Batch Quality Verification

See how PeptideSource verifies a lot before document review.

Sample COA format, lot-code conventions, and the current-batch matching workflow are summarized below. Sample values are clearly marked as demo records; live HPLC/MS and release files are matched by QA.

Sample verification card

PS-CAG-2606-004

Public demo page showing the PeptideSource COA format, QA status, and PDF access pattern.

Current batch request

Matched by SKU + lot ID

Live order documents are supplied after QA confirms the exact product, SKU, and available lot.

Example lot-code format

PS-CAG-2606-321

Format example only. Real batch IDs are assigned from production and release records.

QA review window

5-11 business hours

Typical document-matching window for qualified procurement requests, subject to current batch status.

Laboratory Planning Tool

Plan vial mass, volume, and inventory notes.

Open the calculator as a procurement planning aid for vial mass, diluent-volume records, and target concentration notes. It is not a human-use protocol, administration guide, or clinical recommendation.

Open laboratory calculator

Priority sourcing brief

Cagrilintide sourcing brief for amylin-analog procurement

For qualified buyers, Cagrilintide should be evaluated through identity, commercial fit, and document readiness. Identity fields include CAS 1415456-99-3, formula C194H312N54O59S2, 4409 Da molecular weight. The sourcing checklist is SKU coverage such as 10mg*10vials · 2mg*10vials · 5mg*10vials, ≥99%, batch-file access, MOQ, lead time, and repeat-order suitability.

Compare category

Quick sourcing answer

Identity
CAS 1415456-99-3; PubChem CID 167312356; formula C194H312N54O59S2. Use these public anchors to orient identity, then confirm current batch files before quote approval.
Procurement fit
Useful for distributors, laboratories, and metabolic-category buyers comparing standalone Cagrilintide supply against CagriSema blend requests and broader GLP-1 catalog sourcing.
Document review
Request current COA, HPLC chromatogram, MS identity support, SDS, storage notes, batch number, and fill-size details tied to the quoted SKU.
Comparison path
Compare Cagrilintide by identity, purity basis, batch-document availability, MOQ, lead time, and whether the request is catalog supply or OEM/private-label planning.

Procurement checks

  • Confirm CAS 1415456-99-3, PubChem CID 167312356, formula C194H312N54O59S2, and current batch-document availability.
  • Compare SKU size, fill target, purity basis, MOQ, lead time, and order-wide tier pricing before quote approval.
  • Request COA, HPLC chromatogram, MS identity support, SDS, storage notes, and batch label context tied to the offered lot.
  • Clarify whether the buyer needs standalone Cagrilintide supply, CagriSema component review, or OEM/private-label planning.

Buyer comparison notes

Compared with CagriSema
Cagrilintide is a standalone identity record; CagriSema procurement requires component-level review with Semaglutide context, target fill, and batch-document alignment.
Compared with Semaglutide
Buyers should compare category role, CAS/database identity, vial size, document packet readiness, and repeat supply rather than consumer outcome language.
Bulk-order fit
Best reviewed with target SKU mix, destination market, document needs, label or packaging requirements, and repeat-order cadence.

Technical procurement review

Identity fields buyers should verify first

Cagrilintide should be treated as a named amylin-analog research-material record rather than a generic metabolic-peptide label. The strongest public identity anchors for procurement orientation are CAS 1415456-99-3, PubChem CID 167312356, and formula C194H312N54O59S2. Those fields help align search, quote, and QA language, but supplier approval should still rely on the current batch COA, MS identity file, HPLC purity trace, and label record.

Standalone Cagrilintide vs CagriSema component review

Cagrilintide searches often overlap with CagriSema searches because buyers compare standalone amylin-analog supply with cagrilintide-plus-semaglutide component requests. Procurement should separate those workflows: standalone Cagrilintide needs one identity and batch packet, while CagriSema-style sourcing needs component identity, target fill, ratio or co-pack context, and document support for each relevant component.

What should be in the quote file

A useful Cagrilintide quote file should include requested vial specification, purity basis, minimum order, order-tier pricing, lead time, storage condition, transport note, document availability, and whether the buyer needs sample review, distributor replenishment, or private-label/OEM support. That structure is more useful to B2B buyers than broad claims about outcomes or consumer use.

Search-intent handling for high-risk metabolic queries

Some public searches around Cagrilintide are consumer or treatment oriented. PeptideSource keeps this page focused on research-material procurement, identity verification, documentation, and supplier comparison. Dosing, administration, or outcome questions should be handled outside the catalog through qualified buyer-side review.

Sourcing matrix

ParameterProcurement valueReview note
Identity modelStandalone Cagrilintide research material with CAS 1415456-99-3 and PubChem CID 167312356.Use one molecular identity record for quote review, search matching, and batch-document alignment.
Document packetCOA, HPLC purity report, MS identity support, SDS, storage notes, and batch label context on request.Current files should match the quoted SKU, batch, fill size, and release context.
SKU planningReview vial size, fill target, MOQ, lead time, order tier, and repeat-order expectation before approval.Useful for distributors comparing sample review against bulk procurement.
Comparison pathCompare against CagriSema only as a component-level request, not a single-CAS substitute.Keeps standalone Cagrilintide procurement separate from blend or co-pack sourcing.

Request checklist

  • Current SKU size and fill target
  • COA, HPLC, MS, and SDS document needs
  • MOQ, order tier, and repeat-order estimate
  • Storage, transport, and destination-market requirements

Quality documentation

COA, HPLC, and MS support for this product.

Batch document coverage is summarized below. Qualified buyer packets are matched by product name, SKU, purchase-list item, and confirmed lot during QA review.

COA

Batch-specific certificate available for qualified buyer review.

HPLC

Purity documentation available for every product.

MS

Molecular identity confirmation available on request.

SDS

Safety and handling documents available for procurement review.

Document packet

Document coverage for qualified buyer review

COA

Batch-specific certificate of analysis for buyer review.

HPLC chromatogram

Purity chromatogram available for every product request.

Mass-spec identity

Identity support packet can be matched to the requested SKU.

Residual solvent / counter-ion

Provided when available or required for procurement review.

SDS / MSDS

Safety and handling document available for operational review.

Stability or release support

Shared when relevant to the requested batch or OEM workflow.

Molecular & Structure

CAS
1415456-99-3
Molecular formula
C194H312N54O59S2
Molecular weight
4409

Research Evidence & Regulatory Notes

PeptideSource keeps public identity references and supplier-side documents attached to Cagrilintide as sourcing support. Qualified buyers can request the current COA, HPLC chromatogram, MS identity support, SDS, storage guidance, and applicable batch context before quote approval.

Public Sources & References

PubChempubchem.ncbi.nlm.nih.govEurope PMCeuropepmc.org · 5 recordsClinicalTrials.govclinicaltrials.govA Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or ObesityClinicalTrials.govEfficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study.Aroda VR, Buzzetti R, Dalskov SM, Jain AB, Larsen JH, Mathieu C, Pratley RE, Videmark A, Watt T, Buse JB. · 2026 · Europe PMCCagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study.Buse JB, Bajaj HS, Dalskov SM, Donaldson L, Hansen Duus HH, Fabricius TW, Haluzík M, Lingvay I, Pedersen SD, Pratley RE, Jain AB, REIMAGINE 2 study group. · 2026 · Europe PMCA cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance.Ludwig MQ, Coester B, Gordian D, Hassan S, Tomlinson AJ, Toure MH, Christensen OP, Lommi G, Moltke-Prehn A, Brown JM, Belmont-Rausch DM, Bau S, Bodur C, Gowda A, Wu I, Kernodle S, Dong V, Ayensu-Mensah M, Sabatini PV, Shin JH, Kirigiti M, Egerod KL, Le Foll C, Lundh S, Gerstenberg MK, Lutz TA, Kiev… · 2026 · Europe PMCCagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.Rosenstock J, Billings LK, Gajria R, Giorgino F, Johansen NB, Klein KR, Thamattoor UK, Buse JB, Jain AB. · 2026 · Europe PMCCagrilintide and CagriSema for weight reduction and metabolic risk modification in overweight or obesity: a systematic review and meta-analysis.Rao H, Kumar S, Ali SME, Asif HM, Kumar M, Kumar L, Raja A. · 2026 · Europe PMC

Buyer questions

Common sourcing questions

Can qualified B2B buyers buy Cagrilintide online?

Qualified laboratories, distributors, and procurement teams can select an active SKU and send an online inquiry. PeptideSource confirms current price, MOQ, available lot, documents, destination requirements, and lead time before an order is approved.

Is Cagrilintide for sale with a current COA?

Current batch documentation is confirmed against the exact SKU and lot offered. Request the matching COA, HPLC, MS, SDS, and release context rather than relying on a public sample file as proof of live inventory.

What should a Cagrilintide quote request include?

Include the target SKU, quantity, destination market, document requirements, packaging needs, and expected repeat-order cadence. This page supports research-material procurement and does not provide personal-use, dosing, or treatment guidance.

What makes Cagrilintide different from a generic peptide listing?

Cagrilintide is grouped for metabolic and incretin-pathway research-material sourcing, so the useful procurement review includes incretin, amylin, metabolic-pathway, SKU ladder, and batch-file readiness in addition to identity fields, SKU size, MOQ, and quote terms.

Which quality documents can be requested for Cagrilintide?

Qualified buyers can request COA, HPLC purity support, MS identity context, SDS, storage notes, and batch-specific information when available for the quoted SKU.

How should buyers compare Cagrilintide before approving a quote?

Compare identity fields, category-specific review points, purity basis, SKU size, MOQ, lead time, tier pricing, storage expectations, and document packet readiness.

Does this page provide use instructions for Cagrilintide?

No. The page is written for qualified B2B research-material sourcing, supplier evaluation, and document review only.

Can PeptideSource support bulk or repeat-order review for Cagrilintide?

Yes. Buyers can share target SKU sizes, quantity expectations, document requirements, destination needs, and repeat-order plans for B2B quote review.

Which identity fields define Cagrilintide for PeptideSource sourcing review?

Cagrilintide is reviewed against CAS 1415456-99-3, formula C194H312N54O59S2, 4409 Da. The next check is the current batch packet, including COA, HPLC chromatogram, MS or identity support, and any label or storage notes needed for a procurement file.

How should Cagrilintide searches around vs semaglutide or cagrisema compare be used for sourcing?

vs Semaglutide or CagriSema compare is treated as search context, not as a protocol or outcome claim. PeptideSource people usually check CAS 1415456-99-3, formula C194H312N54O59S2, 4409 Da, SKU coverage such as 10mg*10vials, purity basis, COA/HPLC/MS support, storage notes, and batch-document availability before comparing suppliers.

How does PeptideSource handle COA, HPLC, and MS requests for Cagrilintide?

Send the product name, SKU, or intended purchase-list line and the support team will match available COA, HPLC chromatogram, MS identity support, SDS, storage notes, and related batch context. Documents are shared for qualified buyer, sourcing, and procurement review.

How should Cagrilintide SKU size and fill options be scoped?

Cagrilintide has catalog coverage that includes 10mg*10vials. Buyers should compare the full SKU ladder, minimum order, sales unit, and order-wide tier pricing before deciding whether catalog supply, bulk replenishment, or custom fill review is needed.

How is Cagrilintide compared inside a GLP-1 or metabolic sourcing list?

The comparison is built around molecular identity, CAS record when available, vial or fill ladder, purity basis, salt or counter-ion notes, lead time, tier pricing, and batch-file readiness. Public outcome language is not used as procurement evidence.

Why do searches mention Cagrilintide dosage, route, or reconstitution terms?

Those search terms usually point to public discussions about vial strength, concentration math, handling, and route-of-use language. PeptideSource treats them as search context only. The sourcing review stays with SKU size, purity basis, COA/HPLC/MS support, storage notes, and batch-label information for the buyer's own compliance process.

What storage or stability evidence should accompany Cagrilintide?

Cagrilintide storage should be checked against the batch COA, product label, and logistics notes. When stability or handling details matter for a buyer's workflow, PeptideSource can share available support documents by request.

Research Center

Procurement comparison and document guides

View all guides

Related products

More in Metabolic & GLP-1

Browse category